| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
4e-12 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-11 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
4e-11 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
4e-11 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
6e-11 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
8e-11 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
9e-11 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-10 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
6e-10 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
7e-10 |